Thread
:
I-SPY 2 trial qualifies neratinib for HER2-positive breast cancer
View Single Post
04-08-2014, 01:00 AM
#
1
News
Senior Member
Join Date: Oct 2007
Posts: 18,951
I-SPY 2 trial qualifies neratinib for HER2-positive breast cancer
In an innovative clinical trial led by UC San Francisco, the experimental drug neratinib along with standard chemotherapy was found to be a beneficial treatment for some women with newly diagnosed, high-risk breast cancer.
More...
News
View Public Profile
Send a private message to News
Find More Posts by News